We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 16, 2023

Clinical Outcomes After Taxane Rechallenge in Patients With HER2-Negative Metastatic Breast Cancer

The Breast


Additional Info

Disclosure statements are available on the authors' profiles:

The Breast
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results
Breast 2023 Feb 04;68(2023)149-156, M Réda, A Fouquier, I Desmoulins, D Mayeur, C Kaderbhai, S Ilie, A Hennequin, B Coudert, A Bertaut, S Ladoire

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading